Ser96
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser96  -  RhoGDI alpha (mouse)

Site Information
DLTGDLEsFkkQsFV   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 486318

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:
HeLa (cervical) ( 1 ) , RFPEC (endothelial) ( 1 )

Upstream Regulation
Putative in vivo kinases:
PKCA (human) ( 1 )

Downstream Regulation
Effects of modification on RhoGDI alpha:
activity, induced ( 1 ) , molecular association, regulation ( 1 )
Inhibit interaction with:
GIPC1 (human) ( 1 ) , RHOG (human) ( 1 )

References 

1

Elfenbein A, et al. (2009) Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway. J Cell Biol 186, 75-83
19581409   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.